This tightly regulated balance between ceramide and S1P is increasingly thought to play a key role in cancer development and progression, and AC has been identified as a potential novel therapeutic target which is overexpressed in a number of human cancers, such as prostate and head and neck cancers [10]. This evidence concerns the gene ASAH1 and head and neck cancer.